Trial studying safety and effects for Orthopedic Trauma
Official title Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients
ClinicalTrials.gov ID: NCT07336277
What this study is testing
What is Zolpidem?
Zolpidem is an investigational medicine, given as an once-daily, being studied as a potential treatment for orthopedic trauma.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this study is to determine whether a multimodal sleep pathway can enhance sleep quality in hospitalized patients with orthopedic trauma. It will also evaluate the effect of this pathway on opioid use and pain perception during recovery.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Hospitalized with an isolated lower extremity orthopedic injury requiring surgical intervention.
- Expected hospital stay of at least 3 days.
- No known pre-existing sleep disorders.
- No current use of sleep aids, such as zolpidem or melatonin, before hospitalization
You likely can't join if
- Participants with a history of chronic opioid use prior to hospitalization.
- Pre-existing diagnosed sleep disorders (e.g., obstructive sleep apnea, insomnia).
- Contraindications to zolpidem or melatonin use (e.g., allergies, interactions with other medications).
- Cognitive impairment or inability to comply with study procedures.
- Severe traumatic brain injury or other neurological conditions that may affect sleep or pain perception.
- Participants receiving mechanical ventilation or sedatives that significantly affect sleep architecture.
The study team makes the final eligibility decision.
Where it's taking place
- Atlanta, Georgia, United States
Compensation & support
This study's listing mentions compensation or reimbursement.
No amount is published here - ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.